CD3+ cell infiltration in the tumor tissue was not significantly associated with peripheral lymphocyte counts, TGF-β1 plasma levels, macrophage-derived chemokine (MDC/CCL22) levels, or blood CD3% assessed at study enrollment (Table S4a). The gene discussed is CCL22; the disease is neoplasm.